Back

Cardiac resynchronization therapy in adult congenital heart disease: single center cohort study

31 August 2024 (15:00 - 15:50)
Organised by: Logo
Congress Presentation Part of: Optimising care in adult congenital heart disease Adult Congenital Heart Disease (ACHD) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Ori Rahat

Rabin Medical Centre, Petah Tikva (Israel)

8 More presentations in this session

Presentation thumbnail
Optimising liver screening in patients with a Fontan circulation: a cost-effective approach to detection of Fontan associated liver disease which enhances patient care
Mr H. Mathew (London, GB)
Abstract Slides Video
Presentation thumbnail
Effects of pulmonary hypertension targeted therapy on haemodynamics in pulmonary arterial hypertension associated with adult congenital heart disease: a meta-analysis
Doctor L. Tsigkriki (Chania, GR)
Abstract Slides Video
Presentation thumbnail
A cohort study examining predictors of stroke and bleeding among people with congenital heart disease and atrial fibrillation
Doctor M. O'Shea (Phoenix, US)
Abstract Slides Video
Presentation thumbnail
Reverse cardiac remodeling induced by endovascular treatment of coarctation of the aorta
Assistant Professor M. Farrashi (Tehran, IR)
Abstract Slides Video
Presentation thumbnail
Antithrombotic treatment in univentricular heart
Doctor A. Ozturk (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Optimising care in adult congenital heart disease

The Event

Event poster

ESC Congress 2024

31 August 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Differential outcomes of cardiac resynchronization therapy based on heart failure etiology
thumbnail
Congress Presentation
Implantable Cardioverter-Defibrillator therapy in adult congenital heart disease: insights from long-term follow-up at a tertiary center
thumbnail
Congress Presentation
Personalised approach to resynchronisation therapy in congenital heart disease

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources